A re-evaluation of the mechanisms leading to dengue hemorrhagic fever

Annals of the New York Academy of Sciences

Volumn 1171, Issue SUPPL. 1, 2009, Pages

  Noisakran, Sansanee ^a,b,c   Chokephaibulkit, Kulkanya ^c   Songprakhon, Pucharee ^c   Onlamoon, Nattawat ^a   Hsiao, Hui Mien ^a   Villinger, Francois ^a   Ansari, Aftab ^a   Perng, Guey Chuen ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

dengue virus; DHF; DSS; flavivirus

Indexed keywords

CLINICAL FEATURE; CORRELATION ANALYSIS; DENGUE; DENGUE SHOCK SYNDROME; DENGUE VIRUS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE TRANSMISSION; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFORMATION PROCESSING; INNATE IMMUNITY; MEGAKARYOCYTE; MOSQUITO; NONHUMAN; PILOT STUDY; REVIEW; THROMBOCYTE; THROMBOCYTE DYSFUNCTION; VIREMIA; ARTICLE; BLOOD; CLIMATE; GREENHOUSE EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PUBLIC HEALTH; RNA VIRUS; UNITED STATES; VIROLOGY;

ANIMALIA; DENGUE VIRUS; FLAVIVIRUS;

BLOOD PLATELETS; CLIMATE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; GREENHOUSE EFFECT; HUMANS; IMMUNITY, INNATE; PUBLIC HEALTH; RNA VIRUSES; UNITED STATES; VIREMIA;

EID: 70350450851     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05050.x     Document Type: Review

References (45)

1. Mackenzie, J.S., D.J. Gubler & L.R. Petersen. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis,West Nile and dengue viruses. Nature Med. 10: S98-S109.
2. Barclay, E. 2008. Is climate change affecting dengue in the Americas? Lancet 371: 973-974.
3. NIAID. 2005. Dengue Fever.
4. WHO. 2004. Dengue.
5. Morens, D.M. & A.S. Fauci. 2008. Dengue and hemorrhagic fever: a potential threat to public health in the United States. Jama 299: 214-216.
6. Halstead, S.B. 2007. Dengue. Lancet 370: 1644-1652.
7. Noisakran, S. & G.C. Perng. 2008. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp. Biol. Med. (Maywood) 233: 401-408.
8. Van Der Schaar, H.M., J.C. Wilschut & J.M. Smit. 2009. Role of antibodies in controlling dengue virus infection. Immunobiology. 2009 Mar 2. [Epub ahead of print]. PMID: 19261353.
9. Coffey, L.L. et al. 2009. Human genetic determinants of dengue virus susceptibility. Microbes / Infect. 11: 143-156.
10. Mathew, A. & A.L. Rothman. 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225: 300-313.
11. Green, S. & A. Rothman. 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 19: 429-436.
12. Navarro-Sanchez, E., P. Despres & L. Cedillo- Barron. 2005. Innate immune responses to dengue virus. Arch. Med. Res. 36: 425-435.
13. Fink, J., F. Gu & S.G. Vasudevan. 2006. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev. Med. Virol. 16: 263-275.
14. O'Rourke, F. 1956. Observations on pool and capillary feeding in Aedes aegypti. Nature 177: 1087-1088.
15. Gordon, R.M. &W.H.R. Lumsden. 1939. A study of the behaviour of themouth-parts ofmosquitoeswhen taking up blood from living tissues; together with some observations on the ingestion of microfilariae. Ann. Trop. Med. Parasit. 33: 259-278.
16. Sun, P. et al. 2009. Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 383: 207-215.
17. Nightingale, Z.D., C. Patkar & A.L. Rothman. 2008. Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J. Leuk. Biol. 84: 1028-1038.
18. Kyle, J.L., P.R. Beatty & E. Harris. 2007. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J. Infect Dis. 195: 1808-1817.
19. Wu, S.J. et al. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6: 816-820.
20. Marovich, M. et al. 2001. Human dendritic cells as targets of dengue virus infection. J. Investig. Dermatol. Symp. Proc. 6: 219-224.
21. Dejnirattisai, W. et al. 2008. A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J. Immunol. 181: 5865-5874.
22. Kwan, W.H. et al. 2008. Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl. Trop. Dis. 2: e311.
23. Ader, D.B. et al. 2004. Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva. Viral Immunol. 17: 252-265.
24. Limon-Flores, A.Y. et al. 2005. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int. J. Exp. Pathol. 86: 323-334.
25. Putnam, J.L. & T.W. Scott. 1995. The effect of multiple host contacts on the infectivity of dengue-2 virusinfected Aedes aegypti. J. Parasitol. 81: 170-174.
26. Shepard, D.S. et al. 2004. Cost-effectiveness of a pediatric dengue vaccine. Vaccine 22: 1275-1280.
27. Taweechaisupapong, S. et al. 1996. In vivo and in vitro studies on the morphological change in the monkey epidermal Langerhans cells following exposure to dengue 2 (16681) virus. Southeast Asian J. Trop. Med. Public Health 27: 664-672.
28. Vaughn, D.W. et al. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181: 2-9.
29. Pang, T., M.J. Cardosa & M.G. Guzman. 2007. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol. Cell. Biol. 85: 43-45.
30. Andrews, R.K. & M.C. Berndt. 2004. Platelet physiology and thrombosis. Thromb. Res. 114: 447-453.
31. Michelson, A.D. 2007. Platelets. Academic Press, Elsevier Inc. San Diego, CA.
32. von Hundelshausen, P. & C. Weber. 2007. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100: 27-40.
33. Li, N. 2008. Platelet-lymphocyte cross-talk. J. Leuk. Biol. 83: 1069-1078.
34. Elzey, B.D. et al. 2003. Platelet-mediated modulation of adaptiveimmunity.Acommunication link between innate and adaptive immune compartments. Immunity 19: 9-19.
35. Cohen, S.N. & S.B. Halstead. 1966. Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J. Pediat. 68: 448-456.
36. La Russa, V.F. & B.L. Innis. 1995. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin. Haematol. 8: 249-270.
37. Rosenfeld, S.J. &N.S. Young. 1991.Viruses and bone marrow failure. Blood Rev. 5: 71-77.
38. Srichaikul, T. & S. Nimmannitya. 2000. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract. Res. Clin. Haematol. 13: 261-276.
39. Oishi, K. et al. 2007. Dengue illness: clinical features and pathogenesis. J. Infect. Chemother. 13: 125-133.
40. Edelman, R. et al. 1975. Evaluation of the plasma kinin system in dengue hemorrhagic fever. J. Lab. Clin. Med. 86: 410-421.
41. Saito, M. et al. 2004. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin. Exp. Immunol. 138: 299-303.
42. Boonpucknavig, S. et al. 1979. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am. J. Trop. Med. Hygiene 28: 881-884.
43. Noisakran, S., R.V. Gibbons, P. Songprakhon, et al. 2009. Detection dengue virus in platelets isolated from dengue patients. Southeast Asian J. Trop.Med. Public Health 40: 253-262.
44. Matsumura, T., V. Stollar & R.W. Schlesinger. 1971. Studies on the nature of dengue viruses. V. Structure and development of dengue virus in Vero cells. Virology 46: 344-355.
45. Rahman, S. et al. 1998. Maturation site of dengue type 2 virus in cultured mosquito C6/36 cells and Vero cells. Kobe J. Med Sci. 44: 65-79.